London Stock Exchange welcomes Graft Polymer Plc to the Main Market

The London Stock Exchange today welcomes Graft Polymer (UK) PLC, a business focused on the development of polymer modification, bio/food supplements and drug delivery systems, to the Main Market, trading under the ticker symbol “GPL”.

Graft Polymer is an early-stage company with a state-of-the-art polymer research and development, manufacturing, and operational facility based in Slovenia. The Company has successfully raised £5.0m as part of the IPO financing to fund the accelerated growth, expand the Group’s research and production facility in Slovenia to meet rising customer demand, upgrade existing facilities to enable future IP registration, and increase both inventory and marketing opportunities following expected increased sales.

The Company’s main niche is polymer modification, which is a key global challenge in the polymer industry, and the main instrument for creating modern composite materials. Graft Polymer has developed a unique suite of polymer modification technologies, which can improve existing products and processing methodologies by enhancing performance, simplifying manufacturing, reducing material consumption, widening the choice of feedstocks, and reducing costs.

Quick facts

Market: Main Market
Instrument market cap (£m)
Listing/Admission to trading
06 Jan 2022

Victor Bolduev, chief executive of Graft Polymer, has commented:

“We are delighted to be listing on the London Stock Exchange's Main Market today, a significant milestone in the Company's history. Graft Polymer owns a wide spectrum of patented polymer modification technologies in its portfolio and through the funds we have raised, we will be able to accelerate our plans of development of IP and innovative technologies.”

In 2020, the Group launched GraftBio, a division devoted to developing IP for med-tech product developments including a drug delivery system to support and provide solutions to the market that had been heavily impacted by the COVID-19 pandemic, accelerating growth in the infectious diseases segment of the industry. Graft Polymer’s proprietary set of polymer modification technologies also serves a number of other industries such as construction, packaging, consumer products, clothing, aerospace, and automotive, distinguishing the Company from is competitors.

The Board expects the Group to continue to develop new and innovative polymer technologies both in-house and in conjunction with key industry players and customers.

Looking for new and recent issues?

More recent

London Stock Exchange welcomes The Arab Federation of Capital Markets.

  General Overview 

The Arab Federation of Capital Markets (AFCM) is the Arab industry group for Exchanges and Clearing houses, and Financial Institutions around the Arab regions. It was established in 1978 to be the guiding body for the Arab Stock Exchanges, under the recommendation of the Arab Central Ban

Learn more
London Stock Exchange welcomes EnSilica plc to AIM

EnSilica is a designer and supplier of mixed signal ASICs (Application Specific Integrated Circuit). ASICs are Integrated Circuits or semiconductor chips developed for a particular use or product rather than for general purpose usage.  ASICs help differentiate products through optimised hardware making products smaller, faster, lower power, improved security, add

Learn more
London Stock Exchange Group welcomes The Future Investment Initiative Institute, celebrating the launch of the FII regional summit “Inclusive ESG for Emerging Markets”

The Future Investment Initiative (FII) Institute is a new global nonprofit foundation with an investment arm and one agenda: Impact on Humanity. Global, inclusive and committed to ESG principles, the FII Institute fosters great minds from around the world and turn ideas into real-world solutions in four critical areas: AI and Robotics, Education, Healthcare and Sustainability. The FII Institute

Learn more
European Assets Trust PLC celebrates 50 years.

This year, European Assets Trust PLC celebrates its fiftieth anniversary since launch in May 1972. The Company was created in 1972 following the acquisition of a Dutch investment company ‘Mijbeb NV’ by a consortium of United Kingdom institutional investors and the appointment of a predecessor of BMO Investment Business Limited as its Manager.

Initially the Company was listed solely on

Learn more